AARD Stock Posts

AARD Aardvark Therapeutics3.95-0.46-10.4%

Premarket:3.45-0.50 (-12.7%)

Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials

Globe NewswireFri, 23-Oct 7:00 AM

AARD Aardvark Therapeutics3.95-0.46-10.4%

After Hours:4.95+1.00 (+25.3%)

Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data

Globe NewswireThu, 22-Oct 4:05 PM

AARD Aardvark Therapeutics12.49-0.01-0.1%

Premarket:5.71-6.78 (-54.3%)

Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome

Globe NewswireFri, 27-Feb 4:05 PM

AARD Aardvark Therapeutics12.49-0.01-0.1%

After Hours:6.58-5.91 (-47.3%)

Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome

Globe NewswireFri, 27-Feb 4:05 PM

AARD Aardvark Therapeutics12.49-0.01-0.1%

After Hours:5.99-6.50 (-52.0%)

Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome

Globe NewswireFri, 27-Feb 4:05 PM